These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 12800486)

  • 1. [Disorders in the immune regulation and hemostasis as factors triggering the proliferative retinopathy in diabetes mellitus].
    Zaĭtseva NS; Balashova LM; Teplinskaia LE; Grishin VL; Gankovskaia LV
    Vestn Ross Akad Med Nauk; 2003; (5):28-32. PubMed ID: 12800486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibodies to types II and IV collagens, tumor necrosis factor-alpha and circulating immune complexes in lacrimal fluid and serum of patients with diabetic retinopathy and different stages].
    Balashova LM; Zaĭtseva NS; Teplinskaia LE; Koval'chuk LV; Gankovskaia LV; Obraztsova EN; Aronskind MS
    Vestn Oftalmol; 2000; 116(3):31-4. PubMed ID: 10918849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Manifestations of immunopathology and validation of immunotherapy of diabetic retinopathy].
    Zaĭtseva NS; Dudnikova LK; Slepova OS; Li LS; Smirnova NB; Zueva MV; Kalamkarov GR; Shevchenko TF
    Vestn Oftalmol; 1997; 113(1):27-31. PubMed ID: 9133040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes in the blood serum of patients with diabetes mellitus complicated by angiopathies].
    Afonin AA; Ostashevskaia MI; Poverennyĭ AM
    Ter Arkh; 1982; 54(10):16-7. PubMed ID: 6217572
    [No Abstract]   [Full Text] [Related]  

  • 6. Could diabetic retinopathy be an autoimmune disease?
    Kastelan S; Zjacić-Rotkvić V; Kastelan Z
    Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
    Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
    Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
    Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
    Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic and local immunity in patients with diabetic retinopathy].
    Ekgardt VF; Tarasova LN; Teplova SN; Alekhina TV
    Vestn Oftalmol; 1998; 114(1):46-8. PubMed ID: 9584642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in general hemostasis in patients with diabetic retinopathy].
    Evgrafov VIu; Markova OA; Grishin VL; Efimov VS
    Vestn Oftalmol; 2004; 120(3):29-31. PubMed ID: 15216770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune mechanisms in type-2 diabetic retinopathy.
    Afzal N; Zaman S; Shahzad F; Javaid K; Zafar A; Nagi AH
    J Pak Med Assoc; 2015 Feb; 65(2):159-63. PubMed ID: 25842551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for retinopathy in diabetes mellitus in Kelantan, Malaysia.
    Shriwas SR; Rahman Isa AB; Reddy SC; Mohammad M; Mohammad WB; Mazlan M
    Med J Malaysia; 1996 Dec; 51(4):447-52. PubMed ID: 10968032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
    Zhaboedov GD; Kopaenko AI
    Vestn Oftalmol; 2005; 121(6):29-31. PubMed ID: 16405060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The late complications of diabetes mellitus.
    Squadrito G; Cucinotta D
    Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumeration of CD4(+)CD25(+)T regulatory cells in Type-II diabetes retinopathy.
    Afzal N; Javaid K; Zaman S; Zafar A; Nagi AH
    Pak J Pharm Sci; 2014 Sep; 27(5):1191-7. PubMed ID: 25176359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferative retinopathy in growth-onset diabetes and in maturity-onset diabetes (author's transl)].
    Fischer F
    Wien Klin Wochenschr; 1978 Jun; 90(13):449-52. PubMed ID: 664712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.